Table 2. Highest reported radiographically identifiable complications for each filter type.
| Device (year FDA cleared) | Fracture | IVC perforation | Migration | IVC occlusion |
|---|---|---|---|---|
| ALN (2008) | Case reports (0%)54 55 56 |
3.4% (3.4%)54 |
3% (1.4–3%)57 58 |
Case reports (0%)54 58 59 |
| Recovery (2003/2005a) | 39.5% at 65.7 mo 25% (5.5–25%)10 11 12 13 14 |
100% (27–100%)12 14 |
10% (0–10%)10 12 20 21 |
Case reports (0%)14 |
| G2 (2005/2008a) G2X (2008) Eclipse (2008) Meridian (2011) |
38% at 60 mo 12% (1.2–12%)11 13 15 16 23 60 |
44% (18–44%)15 23 60 61 |
25% (12–25%)15 20 23 |
2.2% (0–2.2%)22 60 |
| Denali (2013) | Case reports62 | 2.5% (2.5%)63 |
Limited data | Limited data |
| Simon Nitinol (1990) | 16% (10–16%)17 18 |
95% (25–95%)17 18 |
5% (0–5%)18 47 |
50% (3.5–50%)17 47 48 49 |
| LGM/Vena Tech LGM (1989) | Case reports64 | Case reports (0%)44 65 | 18.4% (6–18.4%)33 44 45 66 |
65% at 9 y (3.7%/y)45 |
| Vena Tech LP (2001) | Limited data | Case reports (0%)67 | Case reports (0%)67 | Limited data |
| 24F SS Greenfield (1973) | Case reports68 | 15% (2–15%)69 70 |
2% (2%)69 |
5% (2–5%)28 29 71 72 |
| 12F SS Greenfield (1995) | 0.3% (0.3%)73 |
1% (1%)73 |
2.6% (2.6%)73 |
12% (5–12%)31 74 |
| Titanium Greenfield (1989) | 3.8% (3.8%)74 |
50% (13–50% prior to hook modification, 1% with MH design)40 41 |
15% (7.5–15%)33 42 |
20% (3.5–20%)32 75 |
| Günther Tulip (2000/2003a) | 0.3% (0.3%)36 |
78% (22–78%)7 35 36 37 |
12.5% (2.4–12.5%)26 36 43 |
4.1% (2.4–4.1%)36 43 |
| Celect (2007/2008a) Celect Platinum (2012) |
5.6% (4.3–5.6%)39 76 |
93% (22–93%)7 35 38 39 |
4.3% (0–4.3%)38 76 77 |
2.5% (2.5%)38 |
| Bird's Nest (1989) | 4% (3–4%)41 |
85% (85%)34 |
1.1% (1.1%)78 |
4.7% (2.9–4.7%)34 78 |
| Optease (2002/2004a) Trapease (2000) |
50% (0–50%)19 79 80 81 82 83 84 |
Case Reports (0%)79 83 84 | 0.9% (0–0.9%)79 80 81 83 84 |
29% (0.8–29%)46 79 83 84 85 86 |
| Option (2009) | Limited data | 10% (2.9–10%)37 87 |
2% (2%)87 |
4% (4%)87 |
| Crux (2012) | Limited data (0%)88 | Limited data | Limited data (0%)88 |
Limited data (7.2% nonocclusive IVC thrombus)88 |
Abbreviations: FDA, Federal Drug Administration; IVC, inferior vena cava.
Note: For the SafeFlo filter (2009), no significant clinical data are available, and the device is no longer manufactured.
a
Subsequent year when filter was cleared for retrieval indication.